[go: up one dir, main page]

AU2001281734A1 - Method for screening highly active proteases and inhibitors - Google Patents

Method for screening highly active proteases and inhibitors

Info

Publication number
AU2001281734A1
AU2001281734A1 AU2001281734A AU8173401A AU2001281734A1 AU 2001281734 A1 AU2001281734 A1 AU 2001281734A1 AU 2001281734 A AU2001281734 A AU 2001281734A AU 8173401 A AU8173401 A AU 8173401A AU 2001281734 A1 AU2001281734 A1 AU 2001281734A1
Authority
AU
Australia
Prior art keywords
protease
gene
inhibitors
highly active
active proteases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001281734A
Inventor
Mads Norregaard-Madsen
Poul Erik Pedersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Publication of AU2001281734A1 publication Critical patent/AU2001281734A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6408Serine endopeptidases (3.4.21)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)

Abstract

A method of screening a protease gene library for a gene encoding a protease of interest, the method comprising the steps of introducing a first gene of the protease gene library and a second gene encoding a protease inhibitor into a host cell; cultivating the host cell, wherein the cell expresses the first and the second genes to produce a complex of a protease and the inhibitor; dissociating the inhibitor from the complex; and selecting the protease of interest and isolating the encoding gene.
AU2001281734A 2000-08-29 2001-07-17 Method for screening highly active proteases and inhibitors Abandoned AU2001281734A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200001273 2000-08-29
DKPA200001273 2000-08-29
US23001700P 2000-09-05 2000-09-05
US60230017 2000-09-05
PCT/DK2001/000503 WO2002018588A1 (en) 2000-08-29 2001-07-17 Method for screening highly active proteases and inhibitors

Publications (1)

Publication Number Publication Date
AU2001281734A1 true AU2001281734A1 (en) 2002-03-13

Family

ID=8159678

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001281734A Abandoned AU2001281734A1 (en) 2000-08-29 2001-07-17 Method for screening highly active proteases and inhibitors

Country Status (7)

Country Link
US (1) US20040038375A1 (en)
EP (1) EP1315806B1 (en)
AT (1) ATE314465T1 (en)
AU (1) AU2001281734A1 (en)
CA (1) CA2419860A1 (en)
DE (1) DE60116337D1 (en)
WO (1) WO2002018588A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080090745A1 (en) * 2006-10-13 2008-04-17 Fox Bryan P Expression of Streptomyces subtilism inhibitor (SSI) proteins in Bacillus and Streptomyces sp.
US9403897B2 (en) 2011-10-12 2016-08-02 Sanyo Chemical Industries, Ltd. Proteinaceous protease inhibitor and protein solution and detergent composition containing it
JP6591998B2 (en) * 2014-03-28 2019-10-16 ノボザイムス アクティーゼルスカブ Resolubilization of protein crystals at low pH
EP3458600A4 (en) 2016-05-16 2020-01-15 BioMadison, Inc. IMPROVED TEST WITH SYNAPTOBREVIN-BASED FRAGMENT
US12019066B2 (en) * 2016-05-16 2024-06-25 Biomadison, Inc. Assay with synaptobrevin based moiety
CN113166231A (en) * 2018-10-10 2021-07-23 诺维信公司 Chymotrypsin inhibitor variants and uses thereof
AU2023272468A1 (en) 2022-05-14 2024-11-14 Novonesis Plant Biosolutions A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2377392A (en) * 1991-07-09 1993-02-11 Robert Balint A method for the identification of protease inhibitors
US6159688A (en) * 1997-03-18 2000-12-12 Novo Nordisk A/S Methods of producing polynucleotide variants
EP1141382A4 (en) * 1999-01-08 2003-01-08 Bristol Myers Squibb Co Prokaryotic system designed to monitor protease activity

Also Published As

Publication number Publication date
CA2419860A1 (en) 2002-03-07
EP1315806A1 (en) 2003-06-04
WO2002018588A1 (en) 2002-03-07
EP1315806B1 (en) 2005-12-28
ATE314465T1 (en) 2006-01-15
DE60116337D1 (en) 2006-02-02
US20040038375A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
AU8843701A (en) Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
WO2003095636A3 (en) Activation induced deaminase (aid)
WO2003102214A3 (en) Method for efficient rna interference in mammalian cells
WO2004061083A3 (en) Rna interference
AU2001286202A1 (en) Method of culturing mesenchymal stem cells
AU2645097A (en) Auto-deconvoluting combinatorial libraries
PL373399A1 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
WO2002040685A3 (en) Vectors for conditional gene inactivation
DK1576094T3 (en) Methods for forming modified promoters resulting in varying levels of gene expression
AU2001281734A1 (en) Method for screening highly active proteases and inhibitors
AU2001253376A1 (en) Improved process for the conversion of an aqueous biomass hydrolyzate into fuelsor chemicals by the selective removal of fermentation inhibitors
EP1065213A3 (en) HCV polymerase suitable for crystal structure analysis and method for using the enzyme
WO2004022586A3 (en) Tubulysin biosynthesis gene
AU2003231284A1 (en) Seed specific usp promoters for expressing genes in plants
WO2008048407A3 (en) Expression of streptomyces subtilisin inhibitor (ssi) proteins in bacillus and streptomyces sp.
AU2001260314A1 (en) Method for selecting enzyme inhibitors
WO2002018623A3 (en) Methods and reagents for protease inhibition
AU2001265836A1 (en) Method for genome mining for secreted protein genes
AU2002214085A1 (en) Method for producing proteins by electroporation
ATE402998T1 (en) D-HYDANTOINASE FROM OCHROBACTRUM ANTHROPI
WO2003070963A3 (en) Improved protein expression in bacillus subtilis
AU2003241604A1 (en) System and method for screening for protease inhibitors and proteases
WO2002050243A3 (en) The use of ecm degrading enzymes for the improvement of cell transplantation
WO2002018604A3 (en) Methods and compositions for determining isomerase enzymatic activity
AUPQ815500A0 (en) Modification of fructan biosynthesis